In this follow-up episode to Part 1: The Star Decision - Lessons for Directors, HSF Kramer Chair and Senior Partner Rebecca Maslen-Stannage and Head Office Advisory Partner Carolyn Pugsley, turn to the broader governance lessons from the Star decision — including Justice Lee's pointed observations on AI in the boardroom, the growing impracticality of modern board papers, and the role of general counsel and company secretaries.

A must-listen for boards and governance professionals navigating the evolving duties landscape in Australia.

HSF Kramer Chair and Senior Partner Rebecca Maslen-Stannage and Head Office Advisory Partner Carolyn Pugsley, unpack the Federal Court's landmark decision and draw out practical takeaways for NEDs in this two-part podcast series.

In this episode, they discuss the facts and basis of ASIC's allegations, as well as the key outcomes and contributing management and board dynamics (drawing contrasts to other seminal directors' duties cases such as the Centro decision).

In episode two, the discussion turns to the broader governance lessons from the Star decision — including Justice Lee's pointed observations on AI in the boardroom, the growing impracticality of modern board papers, and the role of general counsel and company secretaries.

This is a must-listen for NEDS navigating the evolving duties landscape in Australia.

Export controls and sanctions risk are now a day-to-day issue across the Defence ecosystem - from primes and OEMs to technology and dual use innovators, defence infrastructure contractors and defence focused investors - particularly where programs involve US origin technology, third country collaboration or dual use components.

In this special podcast episode, we share a recent client webinar were partners Leon Chung, Peter Jones and Jonathan Cross explore the export controls issues most likely to arise across Defence procurement, contracting, investment and cross border delivery. The discussion includes a targeted US perspective on ITAR and EAR, with practical insights on managing common pressure points in project timelines and global supply chains. The team also briefly touches on FIRB, highlighting where it can intersect with export controls in Defence transactions and programs, and what teams should be alert to at an early stage.

In Episode 2 of Deal Talk, partners Kam Jamshidi and Nicole Pedler explore what the 2025 NBIO market reveals for bidders and targets in Australian public M&A.
HSF Kramer has deeply analysed non binding indicative offers in public deals to extract the key lessons for bidders and targets when formulating their M&A strategy. Drawing on this proprietary data, the episode examines when NBIOs most commonly emerge and what that means for listed companies facing major announcements, leadership changes and other market moving events.

Kam and Nicole work through the 2025 NBIO landscape, covering:

• success rates
• disclosure practices and timing
• engagement periods
• private equity dynamics
• pre bid stakes
• recent Takeovers Panel developments

A practical discussion for boards, management teams and advisers preparing for, advising on or responding to a potential public M&A approach.

In the latest episode of On Just Terms, HSF Kramer partners Jason Betts and Rebecca Maslen-Stannage are joined by The Honourable Michelle Rowland MP, Attorney-General of Australia, for a wide-ranging discussion on the government's legal priorities.

The Attorney-General shares insights on Privacy Act reform, the government's position on copyright and AI and why there is no text and data mining exception, scams and consumer protection, class actions and access to justice, and the critical importance of effective enforcement capability.

This is a substantive discussion on the role of law in serving the public interest, and what lies ahead on Australia's legal agenda.

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs. There are a lot of interesting topics related to the pharmaceutical sector which we could discuss but today we will be covering the following: 1) First, we will begin with an overview of M&A deal activity in the sector; 2) we will then discuss the key legal trends being seen by our deal teams, 3) finally, we will conclude with a discussion on a hot topic in the industry right now, the rise of China's biotechs on the global stage.

Speakers: Csilla Cao, Siqi Geng

这一期我们会重点讨论制药行业，特别是制药行业并购活动的情况，以及这段时间明显升温的中国生物科技公司对外授权交易。制药行业其实有很多值得讨论的话题，我们这期节目将主要聚焦三个方面：1) 首先，我们会对制药行业的并购交易情况做一个整体介绍；2)再讨论我们交易团队在实际交易中观察到的一些关键法律趋势；3) 最后，我们将重点谈一谈目前行业的一个热门话题，中国生物科技公司在全球舞台的崛起。

Speakers: 曹文旖，耿思琪

It has been a busy time for the Prudential Regulation Authority ("PRA") Enforcement team. In two firsts for the PRA, its decision against U K Insurance Ltd saw the first reported use of the Early Account Scheme leading to a settlement discount of 50%, and the decision against Bank of London Group Limited and Oplyse Holdings Limited involved the first breach of Fundamental Rule 1 by a firm. In this episode of the FSR Brief, Jon Ford, Michael Tan and Emma Bridgeman discuss these recent cases by the PRA and what they signal to firms about the PRA's approach when it comes to early settlement and integrity findings. For more on the Early Account Scheme, read our blog post on the UK Insurance Limited case.

This is the second episode of "Cross-examining AI", HSF Kramer's podcast series on disputes and AI where we unpack the key developments in AI that are shaping litigation. In this episode we give an update on privilege and AI in the US, find out why not to use ChatGPT to develop a corporate strategy, and finally discuss how AI is being used in the world of international arbitration. This episode is hosted by Camilla Macpherson, a knowledge lawyer in our disputes team. Camilla is joined by Alan R. Friedman, a counsel in our New York disputes team, Nick Tonckens, an associate in our New York disputes team and Liz Kantor, a knowledge counsel in our global arbitration team.

Below you can find links to our blog posts on the developments and cases covered in this podcast.

• Civil Justice Council publishes consultation on use of AI for preparing court documents
• New York court finds client chats with generative AI tool Claude are not privileged
• US courts find privilege applies to use of public AI tools by self-represented litigants
• Delaware Court of Chancery reinstates seller CEO and extends earnout payment window, as buyer’s ChatGPT strategy fails
• AI-volution in Arbitration: the new Chartered Institute of Arbitrators (CIArb) Guidelines